{"count": 3, "results": [{"_id": "8557903", "pmid": 8557903, "title": "Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.", "journal": "J Am Coll Cardiol", "date": "1996-02-01T00:00:00Z", "meta_date_publication": "1996 Feb", "meta_volume": "27", "meta_issue": "2", "meta_pages": "337-44", "score": 50057.203, "text_hl": "RESULTS: At 6 months, among @SPECIES_9606 @@@patients@@@ randomized to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, 18.1% died or developed severe @<m>DISEASE_Ventricular_Dysfunction</m> @DISEASE_MESH:D018754 @@@ventricular dysfunction@@@ versus 19.3% of those randomized to no @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (2p = 0.03). ", "citations": {"NLM": "Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. J Am Coll Cardiol. 1996 Feb;27(2):337-44. PMID: 8557903", "BibTeX": "@article{8557903, title={Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.}, journal={J Am Coll Cardiol}, volume={27}, number={2}, pages={337-44}}"}}, {"_id": "7910229", "pmid": 7910229, "title": "GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.", "journal": "Lancet", "date": "1994-05-07T00:00:00Z", "meta_date_publication": "1994 May 7", "meta_volume": "343", "meta_issue": "8906", "meta_pages": "1115-22", "score": 50052.617, "text_hl": "Overall 6-week @DISEASE_Death @DISEASE_MESH:D003643 @@@mortality@@@ was 6.7%. @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@, started within 24 h from @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@AMI@@@ symptoms, produced significant reductions in overall @DISEASE_Death @DISEASE_MESH:D003643 @@@mortality@@@ (odds ratio 0.88 [95% CI 0.79-0.99]) and in the combined outcome measure of @DISEASE_Death @DISEASE_MESH:D003643 @@@mortality@@@ and severe @<m>DISEASE_Ventricular_Dysfunction</m> @DISEASE_MESH:D018754 @@@ventricular dysfunction@@@ (0.90 [0.84-0.98]). ", "citations": {"NLM": "GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet. 1994 May 7;343(8906):1115-22. PMID: 7910229", "BibTeX": "@article{7910229, title={GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.}, journal={Lancet}, volume={343}, number={8906}, pages={1115-22}}"}}, {"_id": "10986582", "pmid": 10986582, "title": "Connective tissue and the heart. Functional significance and regulatory mechanisms.", "journal": "Cardiol Clin", "authors": ["Burlew BS", "Weber KT"], "date": "2000-08-01T00:00:00Z", "doi": "10.1016/s0733-8651(05)70154-5", "meta_date_publication": "2000 Aug", "meta_volume": "18", "meta_issue": "3", "meta_pages": "435-42", "score": 50049.664, "text_hl": "Experimental and clinical findings with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive heart disease@@@, where @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@cardiac fibrosis@@@ and @<m>DISEASE_Ventricular_Dysfunction</m> @DISEASE_MESH:D018754 @@@abnormal ventricular stiffness@@@ are present, indicate that such cardioreparation should be a targeted objective of pharmacologic intervention. ", "citations": {"NLM": "Burlew BS, Weber KT. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin. 2000 Aug;18(3):435-42. PMID: 10986582", "BibTeX": "@article{10986582, title={Connective tissue and the heart. Functional significance and regulatory mechanisms.}, author={Burlew BS and Weber KT}, journal={Cardiol Clin}, volume={18}, number={3}, pages={435-42}}"}}]}